BCL2 and cancer: The Bcl-2 family of apoptotic proteins is involved in cancer cell survival and proliferation, and combination of Bcl-2 inhibitor ABT-737 and mTOR inhibitor AZD8055 was highly synergistic in inducing caspase-dependent apoptosis in ARMS and ERMS cells (Preuss et al., 2013).